Measles mumps/rubella
Ended Awarded Last action
- Contract number
- SPE2DR26FX1PL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,776
Award facts
- Contract value 100% obligated
- $11,775.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 24, 2026, with a ceiling value of $11,775.80 for measles, mumps, and rubella vaccine supply. Place of performance is Conshohocken, PA. Ultimate completion date is March 25, 2026. The order is issued under firm fixed-price terms with no set-aside.
Quick answers
Who was awarded contract SPE2DR26FX1PL?
SPE2DR26FX1PL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 24, 2026.
How much is contract SPE2DR26FX1PL worth?
The government has obligated $11,776 on SPE2DR26FX1PL.
Is contract SPE2DR26FX1PL an order under another contract?
Yes. SPE2DR26FX1PL is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FX1PL competed?
The extent of competition for SPE2DR26FX1PL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award